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PROTODYNE:
AN EMMUNOSTIMULATORY PROTEIN COMPONENT, 
PREPARED FROM GRAM-POSITIVE BACILLUS SUBTILIS
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J, W.M. Van Der Meer\  M.M. Philippeaux*, J . Vilcek5 and M. T.E. Vogels1
ABSTRACT
A protein component derived from bacterial protoplasm, called Protodyne, 
increases the non-specific resistance to infections by bacteria and viruses. Here we show 
that Protpdyne can be prepared not only from Gram-negative bacteria, but also from 
Gram-positive bacilli. Several preparations of Protodyne, prepared from Bacillus sub- 
tilis by phenol extraction or by ammonium sulfate precipitation, were evaluated for 
immunomodulatory activities in a variety of assays. Protodyne had a marked mitogenic 
activity on mouse spleen cells; it was a potent inducer of tumor necrosis factor (TNF) 
and stimulated production of interleukin-1 (IL-1) in human peripheral blood 
mononuclear cells; it increased the capacity of activated macrophages to undergo a 
respiratory burst, to produce intracellular killing of leishmanial parasite and extracellu­
lar lysis of mastocytoma cells; it also stimulated phagocytosis of latex particles, and 
prolonged survival of immunosuppressed mice infected with Pseudomonas aeruginosa. 
These activities were not inhibited by polymyxin B, indicating that the activity of Proto­
dyne is not the result of contamination with exogenous lipopolysaccharide. It appears 
that Protodyne exerts its many immunomodulatory actions by inducing the release of 
soluble mediators, including TNF and IL-1.
INTRODUCTION
Protodyne, a protein component derived from bacterial protoplasm, was 
originally prepared from Gram-negative bacteria (e.g. Escherichia coll) by extrac­
tion with hot phenol and subsequent precipitation of the phenol phase with cold 
methanol (2). This isolation procedure distinguished Protodyne from endotoxin 
(lipopolysaccharide - LPS) derived from bacterial cell walls also by phenol extrac-
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tion, but which was located in the aqueous phase (15). However, the fact that Pro­
todyne exerted activities similar to LPS raised a question of possible contamina­
tion of Protodyne with LPS. Chemical composition and several other differences 
distinguished both preparations: in contrast to LPS, Protodyne was 
predominantly a protein and contained less than 1 % of carbohydrates and lipids, 
had low toxicity, no pyrogenicity, did not contain 2-keto-3-deoxyoctonate, and 
was non-reactive in Limulus amebocyte lysate assay (2, 3, 7, 12). Either prepara­
tion, Protodyne or LPS, prepared from Gram-negative bacteria, increased sur­
vival of animals infected with lethal doses of various micro-organisms (1, 2, 3), 
but the actual mechanisms by which Protodyne leads to the increased resistance, 
were not studied in detail.
Here we show that Protodyne can be prepared not only from Gram-negative 
bacteria, but also from Gram-positive bacilli considered not to contain LPS. 
Several batches of Protodyne were prepared from Bacillus subtilis, either by the 
original extraction with hot phenol and subsequent precipitation with cold 
methanol (A-41886) or by precipitation with ammonium sulphate at 75% satura­
tion (AS). The samples of Protodyne were distributed to collaborating institutions 
for the determination of biological activities. Polymyxin B (PMXB), an agent 
known to inhibit the biological activities of LPS (9) was used in most of the experi­
ments.
METHODS
The methods used are described in References,
RESULTS
Mitogenic activity
The proliferation of murine spleen cells, measured by 3H-thymidine uptake, 
was stimulated by Protodyne in a dose-dependent fashion as shown in Figure Í-A 
(full line). This activity was not inhibited by the addition of PMBX (dotted line).
Tumor necrosis factor (TNF)
Protodyne also stimulated TNF production by human peripheral blood mono­
cytes, measured by a sensitive TNF bio-assay (6) using human rhabdomyosar­
coma A-673/6 cells, as shown in Figure 1-B (full lines = 3,6 and 24 hours incuba­
tion). PMXB did not abrogate TNF induction (dotted line).
Interleukin-1 -beta (IL-l-beta)
The production of IL- 1-beta by human peripheral blood monocytes, as meas­
ured by radio-immunoassay (5,13), was stimulated by Protodyne and this activity 
was not reduced by PMXB (Table I).
Respiratory burst
Respiratory burst, measured by hexose-monophosphate shunt assay (4), using 
mouse peritoneal macrophages, was only slightly stimulated by Protodyne in non­
activated cells (Fig. 2-A, lower part, full line). However, a high stimulation was
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Fig. 1. Stimulation o f  mitogenic responses and TNFproduction by Protodyne A-41886 alone (full 
lines) and with 20 (xg/mi of polymyxin B (dotted lines). — A. Stimulation of proliferation of murine 
spleen cells by different doses of Protodyne measured by 3H-thymidine uptake. B. Stimulation of 
TNF production from human peripheral blood monocytes by Protodyne at 3 hrs (O), 6 hrs (A) and
20 hrs (□ ) incubation.
Table I. Stimulation of Interleukin-1 production by human peripheral blood monocytes in vitro.
Test samples Donor I Donor II
PMXB - + - +
Controls (PB S).............  , <0.03* <0.03 <0.03 <0.03
LPS (1 |xg/ml) . ............. 8.50 <0.03 9.75 0.03
Protodyne (jjtg/ml)
1 .0 .............................. <0.03 <0.03 0.037 0.037
1 0 .0 ................... .......... 11.25 12.00 12.50 11.70
100.0 .............................. 9.25 9.75 13.20 13.25
* Total IL-1 (ng/ml), means of triplicates.
Human peripheral blood mononuclear cells from two donors were stimulated in culture by Protodyne 
or LPS for 24 hours in the absence (PMXB - )  or presence (PMX3 +) of polymyxin B (5 jig/ml) added 
together with test compounds. Total IL-1 was determined by RIA as described in Methods. The num­
bers represent the means of triplicate estimations.
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Fig. 2. Respiratory burst (HMPS) and intracellular parasite killing by peritoneal murine macrophages 
in the presence (O) or absence (□) of MAF. Stimulation by Protodyne A-41886 without (full lines) 
or with (dotted lines) polymyxin B (1 ¡xg/ml). — A. B ALB/c peritoneal macrophages were incubated 
with test samples for 24 hrs at 37°C; after washing with glucose-free HBSS, the cells were reincubated 
with [1-14C] glucose for 120 min, af which time the amount of 14C 02(cpm) evolved by the cells was 
measured. — B. L. enriettii parasitized BALB/c peritoneal macrophages were incubated with test sam­
ples for 24 hrs at which time intracellular killing was determined after SDS lysis of macrophages, by 
the uptake of 3H-thymidine by the surviving parasites.
observed in macrophages activated by macrophage activating factors (MAF) as 
shown in the upper part. PMXB did not markedly inhibit this activity (dotted 
lines).
Intracellular killing of parasites (8)
 ^Murine macrophages, exposed to Protodyne in the absence of MAF, did not 
induce intracellular killing of protozoan parasites (Leishmania enrietti) as shown 
in Figure 2-B (lower part). However, a substantial killing of the parasites was 
induced by macrophages activated by MAF, even at low concentrations of Proto­
dyne (Fig. 2-B, upper part, full line). PMXB had little effect on this activity (dot­
ted lines).
Cytotoxicity
The extracellular cytolytic capacity of macrophages activated by MAF, meas­
ured by specific release of 51Cr from prelabelled mastocytoma cells (11), was 
stimulated by Protodyne in a dose-response manner as shown in Figure 3-left part. 
Again, this activity was not influenced by added PMXB.
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Fig. 3. Dose-response effect o f  Protodyne A-41886 to stimulate the extracellular capacity of macro­
phages, activated by MAJF, to lyse mastocytoma cells prelabelled with 5ICr. Specific release of 51Cr 
was calculated and expressed as a percentage (A). The effect of polymyxin B (50 [xg/ml) on the activity 
of Protodyne in comparison with LPS (B) is a representative result of 15 different fractions of Proto­
dyne tested.
Phagocytosis (10)
Protodyne stimulated in vitro phagocytosis of latex particles by mouse 
peritoneal macrophages (Tables II) but not by peripheral blood leukocytes. 
However, intra-peritoneal injections of Protodyne to animals 1 to 24 hours before 
bleeding increased the phagocytic activity of peripheral blood leukocytes in vitro 
in a dose-dependent fashion as shown in Figure 4.
Survival of mice
Table III shows the effect of Protodyne on the survival of mice, severely 
immunosuppressed by cyclophosphamide and infected with lethal doses of Pseu- 
domonas aeruginosa (14). Protodyne, injected 24 hours before infection, signifi­
cantly increased the survival of mice, as compared with controls injected with 
saline.
The biological activities of Protodynes prepared by different procedures are 
compared in Table IV. There was no substantial difference in the activities of the 
preparations indicating that ammonium sulphate precipitation, which provided a 
water soluble product, might be a useful step for further purification to homo­
geneity and eventual identification.
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Table II. Phagocytosis of latex beads by mouse adherent peritoneal exudate cells (macrophages)
in vitro.
Test samples % of phagocytic 
cells
No of beads 
in 100 cells
PI*
Saline.......................................... 40** 67 2.7
LPS (10 [xg/ml)......................... 49 111 5.4
Protodyne ((¿g/ml)
1 0 .0 .......................................... 44 97 4.3
20 .0 ...................................... 57 100 5.7
100.0...................................... 64 120 7.7
Mouse (C-58) adherent peritoneal exudate cells were incubated in microslide chambers with latex beads 
(labelled with fluorescein) and the test samples for 1.5 hrs at 37°C in 5% C 02 and examined under 
the UV-microscope. Thé number of cells in 100 containing beads (% phagocytic cells) and the number 
of beads in those 100 cells were recorded for calculation of Phagocytic Index (PI):
Vo phagocytic cells x No. beads/100 cells
*PI= ---------------------------------------
1,000
** The numbers represent the means of at least three experiments.
Phagocytosis
Hours after Injection
Fig. 4. Kinetics o f phagocytosis stimulation by Protodyne A-41886. — Mice B ALB/c and C3H/HeJ 
were injected intraperitoneally with different doses of Protodyne (as indicated) and with saline. 
Heparinized blood samples from mice, sacrificed at different time intervals, were mixed with Fluores- 
brite (Latex) particles and incubated for 1 hr at 37°C. The smears were prepared on slides, stained 
by Giemsa and examined under the UV-microscope. Phagocytosis Index (PI) was calculated as
described in Methods.
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Table III, Effect of Protodyne treatment on the survival of immunosuppressed mice infected with
P. aeruginosa.
Hours after 
infection
Saline
(controls)
Protodyne (rag/kg) Interleukin-I (fig/kg)
0.1 1.0 10.0 3.0 30.0
24 17/24 
(71 %)**
23/23
(100%)
22/24
(92%)
24/24
(100%)
20/20
(100%)
24/24
(100%)
30 0/24
(0%)
7/23
(30%)
13/24 ì 
(54%)
20/24
(83%)
14/20
(70%)
20/24
(83%)
36 0/24
(0%)
2/23
(9%)
4/24
(17%)
9/24
(38%)
9/20
(45%)
7/24
(29%)
48 0/24
(0%)
0/23
(0%)
0/24
(0%)
1/24
(4%)
1/20
(5%)
0/24
(0%)
Significance versus 
controls:
'X2 = 3.72 6.29 15.39 9.66 15.28
P = >0.05 <0.05 <0.001 <0.01 <0.001
* Number of survived/total number of animals. 
** % of survivors.
Mice, immunosuppressed by cyclophosphamide (150 mg/kg-4 days and 100 mg/kg-one day before 
infection), were infected with Ps. aeruginosa. Test compounds (Protodyne, interleukin-1 and saline) 
were given as a single i.p. injection 24 hours before infection. 20 to 24 mice were used in each group. 
Survival of mice was recorded at intervals of 24, 30, 36 and 48 hours.
Table IV. Comparison of activities of Protodyne (B. subtilis) prepared by different procedures.
Protodyne Mitogenic
activity
(c.p.m.)*
Tumor
necrosis
factor
(pg/ml)
Cytotoxicity 
(specific 
51Cr release)
m
Parasite
killing
TO
Phagocyto­
sis PMNs 
in vivo 
(specific PI)
Method of preparation Concen­
tration
10 [ig/ml 10 (ig/ml 50 (ig/ml 10 jig/ml 8 mg/kg
Phenol extraction 5,980 6,000 79 100 15.39
Precipitation by 
ammonium sulphate 7,490 6,500 81 Not done 11.17
Sephacryl S-400 1st 
(pooled) fraction 10,600 4,000 87 100 16.36
* c.p.m. of background deducted.
CONCLUSION
The data presented clearly indicate that the activity of Protodyne is not the 
result of contamination with exogenous lipopolysaccharide. It appears that Proto­
dyne exerts its many immunomodulatory actions by inducing the release of solu­
ble mediators, including TNF and IL-1.
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